FIELD: medicine.
SUBSTANCE: method involves determining system injury labels A, where A=0 corresponds to no potentially dangerous injury being recognized; A=1 to availability of marked alteration with injury markers generalization like incompatible group blood transfusion, heavy traumas with hemorrhage with more than 1 l of blood lost, or visceral organ injury, burns of 3-4th severity degree with more than 10% of body surface area, heavy poisonings, sharp pyoinflammatory diseases satisfying to 2-4 SIRS criteria, development of anaphylactic system response; A=2 corresponds to availability of injuries being classified as critical conditions risk factor; intensity inflammatory system response manifestations B, where В=1 corresponds to availability of D-dimers in concentration greater than 3 mcg/ml or fibrin-monomer complexes or > 20 mcg/ml; availability of early stage organ microcirculation injury labels C, where C=1 corresponds to myoglobin level greater than 60 ng/ml with no signs of marked muscle tissue injury or greater than 800 ng/ml without injury conditions, or troponin level I- 0.2-1.0 ng/ml or greater than 1 ml when excluding primary myocardial infarction. Organ dysfunction is estimated in SOFA scale. Critical condition is evaluated as D where D=1 corresponds to 2-5 points of SOFA scale; D=2 corresponds to critical condition statement in the following cases. 1) 6-24 SOFA points, 2) 2-5 SOFA points with clinical multiple organ failure/dysfunction symptoms being available, 3) shock or decompensated disseminated intravascular coagulation syndrome phase availability. Emergency state development risk factors are determined, where F=1 shows to additional risk factors availability like age >60 years, immune deficiency states, diabetes mellitus, chronic cardiac or pulmonary insufficiency availability in anamnesis. A=1 and B=1 being found to take place, inflammatory system response syndrome is diagnosed. The case of A=1 and B=1 (with C=1 or D=1 and F=1 as well), or A=2, emergency state development risk caused by inflammatory system response syndrome is to be predicted. D=2 and/or A=2 being the case, emergency state is diagnosed.
EFFECT: high accuracy in estimating inflammatory system response syndrome development risk.
3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MONITORING CRITICAL STATES DEVELOPMENT ASSOCIATED WITH INFLAMMATORY SYSTEMIC RESPONSE SYNDROME | 2005 |
|
RU2293333C2 |
METHOD FOR DIAGNOSING SYSTEMIC INFLAMMATORY RESPONSE OF ORGANISM FROM MAIN BLOOD PLASMA EOSINOPHIL CATIONIC PROTEIN | 2005 |
|
RU2312357C2 |
METHOD FOR PREDICTION OF SEPSIS FOLLOWING CARDIOSURGICAL OPERATIONS PERFORMED IN CONDITIONS OF ARTIFICIAL BLOOD CIRCULATION | 2019 |
|
RU2713930C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF INFECTIOUS COMPLICATIONS AND SEPSIS IN PATIENTS WITH A SEVERE TRAUMATIC BRAIN INJURY | 2020 |
|
RU2743806C1 |
METHOD OF REPLACEMENT SELENOTHERAPY IN SEPTIC ENCEPHALOPATHY | 2023 |
|
RU2802154C1 |
METHOD FOR PREDICTING ABDOMINAL SEPSIS SEVERITY DEGREE | 2004 |
|
RU2259159C1 |
METHOD OF PREDICTION OF DEVELOPING SUPPURATIVE COMPLICATIONS OF PANCREATONECROSIS AT EARLY STAGES OF DISEASE | 2015 |
|
RU2605851C1 |
HISTONES AND/OR proADM AS MARKERS TESTIFYING ABOUT ORGAN DYSFUNCTION | 2017 |
|
RU2764766C2 |
HISTONES AND/OR proADM AS MARKERS INDICATING ADVERSE EVENT | 2017 |
|
RU2765212C2 |
METHOD OF PREDICTING OUTCOME OF BURNING INJURY | 2008 |
|
RU2368320C1 |
Authors
Dates
2007-05-20—Published
2005-03-28—Filed